Cancer News and Research

Latest Cancer News and Research

Seven EU-funded projects tackle the scourge of environmental pollutants

Pollution affects us all, from the air we breathe, to the water we drink, to the food we eat. Sometimes it may not be very noticeable that we're breathing in polluted air, for example, but pollution is actually the largest environmental cause of multiple mental and physical diseases, as well as premature deaths, particularly amongst children, people with certain medical conditions and elderly citizens.

22 May 2021

FDA approves Rybrevant for treating subset of non-small cell lung cancer

Today, the U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of genetic mutations: epidermal growth factor receptor (EGFR) exon 20 insertion mutations.

21 May 2021

Campylobacter infection can also be spread through sexual contact

Campylobacter infection, one of the most common foodborne illnesses in the Western world, can also be spread through sexual contact, according to a new research discovery by an OU Hudson College of Public Health faculty member, working in conjunction with colleagues in Denmark.

21 May 2021

Study could lead to new antibiotics to fight bacterial infections

One member of a large protein family that is known to stop the spread of bacterial infections by prompting infected human cells to self-destruct appears to kill the infectious bacteria instead, a new study led by UT Southwestern scientists shows.

21 May 2021

Parents and young adults urged to get HPV vaccination back on track

Sanford Burnham Prebys has joined doctors and scientists across America at National Cancer Institute (NCI)-designated cancer centers and other organizations to issue a joint statement urging the nation's physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track.

21 May 2021

Penn University more than doubles the percentage of Black patients in cancer clinical trials

A five-year community outreach and engagement effort by the Abramson Cancer Center at the University of Pennsylvania (ACC) to increase enrollment of Black patients into cancer clinical trials more than doubled the percentage of participants, improving access and treatment for a group with historically low representation in cancer research.

21 May 2021

Should colorectal cancer screening start at age 45?

Colorectal cancer rates among young adults are steadily increasing over the years. The United States Task Force has long recommended that people aged 50 to 75 get screened. Now, the U.S. Preventive Services Task Force updated its 2016 recommendation of colorectal screening for people aged 50, down to 45 years old. The five-year earlier screening can save many lives by allowing earlier diagnosis and treatment of the condition.

21 May 2021

Facets of SARS-CoV-2 infection and animal models

A new study in the journal Frontiers in Cell and Developmental Biology discusses the ribonucleic acid (RNA) genome of the virus, and the mechanisms by which it establishes infection within the host cell. The researchers also summarize the development of animal models of COVID-19, which will both help understand the clinical features of the illness, and indicate new approaches for the treatment of the infection.

21 May 2021

Biognosys Announces the Appointment of Kristina Beeler as Chief Business Officer

Biognosys announces the appointment of Kristina Beeler as Chief Business Operator

From Biognosys 21 May 2021

New study may lead to better treatments for prostate, ovarian, and breast cancers

Researchers at UVA Cancer Center have unveiled important new insights into how hormones known as androgens act on our cells – and the discovery could boost efforts to develop better treatments for prostate, ovarian and breast cancers.

21 May 2021

Adaptimmune to report Phase 2 trial data on synovial sarcoma at ASCO congress

Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, will report initial data from its Phase 2 SPEARHEAD-1 trial, with afamitresgene autoleucel (afami-cel, formerly ADP-A2M4), at the American Society of Clinical Oncology (ASCO) congress. Full abstracts were released online today.

21 May 2021

Study demonstrates the negative effects of HERV activation on human brain development

Since our ancestors infected themselves with retroviruses millions of years ago, we have carried elements of these viruses in our genes - known as human endogenous retroviruses, or HERVs for short.

21 May 2021

Targeting mTOR pathway can improve the effectiveness of chemotherapies for pediatric brain cancer

Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness of standard chemotherapies for a highly aggressive type of pediatric brain cancer.

21 May 2021

Survey assesses health care delays during COVID-19 outbreak

At the start of the COVID-19 outbreak, a University of Illinois Chicago researcher conducted a survey asking respondents if they experienced health care delays because of the pandemic. In addition to learning about the types of delays, the study also presented a unique opportunity to capture a historic moment at the pandemic's beginning.

21 May 2021

Medicaid-Medicare partnership could cover lifesaving medications for hepatitis C

Untreated hepatitis C can lead to serious and life-threatening health problems like cirrhosis and liver cancer. Direct-acting antiviral therapies introduced in recent years are highly effective, with cure rates above 95%.

21 May 2021

Blocking TGFβ1 could improve hematopoiesis in AML patients, indicates study

Bone marrow failure due to acute myeloid leukemia (AML) is a significant factor behind the disease's high rate of morbidity and mortality. Previous studies in mice suggest that AML cells inhibit healthy hematopoietic (blood) stem and progenitor cells (HSPC).

20 May 2021

Cancer occurs through multiple steps that resurrect ancient cellular functions, suggests new model

In spite of decades of research, cancer remains an enigma. Conventional wisdom holds that cancer is driven by random mutations that create aberrant cells that run amok in the body.

20 May 2021

Extensive cancer research data to be presented at the 2021 ASCO Annual Meeting

Rutgers Cancer Institute of New Jersey, a leader in cutting-edge clinical trials and health outcomes analyses and a designated Comprehensive Cancer Center by the National Cancer Institute, together with RWJBarnabas Health, today announced that data from its cancer clinical research program will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held virtually from June 4-8.

20 May 2021

A better understanding of brain fluid movements can help predict and treat Alzheimer's disease

Scientists don't fully understand what causes Alzheimer's disease, but they have a primary suspect.

20 May 2021

Monoclonal antibody bamlanivimab reduces hospitalization and death in moderate-to-severe COVID-19

Researchers at the University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center found that monoclonal antibodies, a COVID-19 treatment administered early after infection, reduce the risk of hospitalization and death by 60 percent in people at high risk of suffering complications from the condition.

20 May 2021

Cancer News and Research

Latest Cancer News and Research

Seven EU-funded projects tackle the scourge of environmental pollutants

FDA approves Rybrevant for treating subset of non-small cell lung cancer

Campylobacter infection can also be spread through sexual contact

Study could lead to new antibiotics to fight bacterial infections

Parents and young adults urged to get HPV vaccination back on track

Penn University more than doubles the percentage of Black patients in cancer clinical trials

Should colorectal cancer screening start at age 45?

Facets of SARS-CoV-2 infection and animal models

Biognosys Announces the Appointment of Kristina Beeler as Chief Business Officer

New study may lead to better treatments for prostate, ovarian, and breast cancers

Adaptimmune to report Phase 2 trial data on synovial sarcoma at ASCO congress

Study demonstrates the negative effects of HERV activation on human brain development

Targeting mTOR pathway can improve the effectiveness of chemotherapies for pediatric brain cancer

Survey assesses health care delays during COVID-19 outbreak

Medicaid-Medicare partnership could cover lifesaving medications for hepatitis C

Blocking TGFβ1 could improve hematopoiesis in AML patients, indicates study

Cancer occurs through multiple steps that resurrect ancient cellular functions, suggests new model

Extensive cancer research data to be presented at the 2021 ASCO Annual Meeting

A better understanding of brain fluid movements can help predict and treat Alzheimer's disease

Monoclonal antibody bamlanivimab reduces hospitalization and death in moderate-to-severe COVID-19

Industry Focus eBook: Oncology eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook: Oncology eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in